Welcome!
Tiger Balm
Broker's Calls
Haw Par trading below historical book value, CGSI highlights in unrated report
Post Covid-19, FY2023 saw a rebound with the group's healthcare business revenue recovering to $213.5 million.
July 11, 2024
SGX Research Series: 10 in 10
After more than a century, Haw Par continues to ride the Tiger and won't get off
“Haw” and “Par” means “tiger” and “leopard”, respectively in Hokkien.
March 26, 2021
Results
Haw Par's roar muffles with a 19.1% drop in earnings to $91.0 mil in 1H2020
Haw Par has recommended a first and interim dividend of 15 cents for the period, to be paid in September. The same amount was paid out in 1H2019.
August 12, 2020
Results
Haw Par roars to 10.2% rise in 2Q earnings to $90.5 mil on continued demand for Tiger Balm
SINGAPORE (Aug 7): Haw Par Corporation saw its earnings grow 10.2% to $90.5 million for the 2Q19 ended June, from $82.1 million a year ago, on the back of higher operating profit and dividend income.
August 07, 2019
Results
Haw Par posts 21.8% higher 1Q earnings of $17.3 mi on revenue growth
SINGAPORE (May 11): Haw Par Corp, the manufacturer of Tiger Balm ointment with interest in the leisure and property sectors, has announced 1Q17 earnings of $17.3 million, up 21.8% from the $14.2 million the year before.
May 11, 2017
Haw Par posts 27% rise in 1Q earnings to $17.1 mil
SINGAPORE (May 11): Tiger Balm ointment maker Haw Par Corp posted a 26.8% rise in 1Q earnings to $17.1 million from a year ago. This came on the back of a 14.9% rise in revenue to $52.3 million and a more than tripling of other income to $4.8 million.
May 11, 2016